home.aspx

 
.

CLOSING THE PRODUCTION GAP IN GENE THERAPY – A SCALABLE HELPER VIRUS-FREE AAV PRODUCTION PLATFORM

July 11, 2019
USA (United States of America)
With gene therapy projects moving towards more common diseases, such as Rheumatoid Arthritis, Parkinson´s disease or Alzheimer´s disease, there is a growing need for large-scale viral vector production, in particular for adeno-associated viral (AAV) vectors. However, current production systems rely on transient plasmid transfection or helper viruses and are thus hardly scalable. The webinar will address solutions to overcome this production gap in gene therapy.